Proteomic Analysis of Danlou Tablet in Improving Platelet Function for Treating Coronary Heart Disease with Phlegm-stasis Intermingling Syndrome in Minipigs
|更新时间:2026-02-28
|
Proteomic Analysis of Danlou Tablet in Improving Platelet Function for Treating Coronary Heart Disease with Phlegm-stasis Intermingling Syndrome in Minipigs
增强出版
“Expert research has found that Danlou tablets can effectively reduce platelet activation and aggregation, and have good therapeutic effects on coronary heart disease with phlegm blood stasis syndrome in small pigs. Its pharmacological mechanism involves regulating biological pathways such as actin cytoskeleton and platelet activation pathway, as well as proteins such as GRB2 and RAC2.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 32, Issue 5, Pages: 41-53(2026)
WANG Ziyan,LI Ying,WANG Aoao,et al.Proteomic Analysis of Danlou Tablet in Improving Platelet Function for Treating Coronary Heart Disease with Phlegm-stasis Intermingling Syndrome in Minipigs[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(05):41-53.
WANG Ziyan,LI Ying,WANG Aoao,et al.Proteomic Analysis of Danlou Tablet in Improving Platelet Function for Treating Coronary Heart Disease with Phlegm-stasis Intermingling Syndrome in Minipigs[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(05):41-53. DOI: 10.13422/j.cnki.syfjx.20252206.
Proteomic Analysis of Danlou Tablet in Improving Platelet Function for Treating Coronary Heart Disease with Phlegm-stasis Intermingling Syndrome in Minipigs增强出版
Effect and Mechanism of Xiao Qinglongtang Against Right Ventricular Dysfunction in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline
Effect and Mechanism of Xiao Qinglongtang Against Right Ventricular Dysfunction in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline
Proteomics-based Investigation of Therapeutic Effect and Mechanism of Verbenalin on Lung Injury in Mice Infected with Human Coronavirus-229E
Mechanism of Huangqi Gegen Decoction in Treatment of Type 2 Diabetes Mellitus via Intestinal Mucosal Barrier
Related Author
QI Lei
ZHANG Huifei
GONG Ling
HE Jifu
CHEN Wenjing
NIU Weipin
LI Xiao
JIANG Yuehua
Related Institution
The Affiliated Hospital of Shandong University of Traditional Chinese Medicine(TCM)
Shandong University of TCM
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
Shanxi Key Laboratory of Innovative Drug for Treatment of Serious Diseases Basing on Chronic Inflammation,College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine